Global Bacterial Disease Diagnostics Market 2019-2023
A key factor driving the growth of the global bacterial disease
diagnostics market size is the integration of digital health in rapid
diagnostics for bacterial disease. The healthcare information technology
(IT) segment has been very promising in the area of microbiology, as it
has helped to understand various resistant bacterial strains. Digital
health is increasingly being used in bacterial disease diagnostics to
enhance accuracy levels, convenience, and affordability of various types
of rapid diagnostics tests. The development of new diagnostics
incorporated with digital technologies is helping healthcare
professionals identify bacterial strains and provide better target
appropriate treatment. Vendors are focusing on developing mobile
applications that support portable rapid diagnostic systems to enable
improved accuracy of tests. All these developments are expected to boost
market growth over the forecast period.
Global bacterial disease diagnostics market: High sensitivity and accuracy of chemiluminescence immunoassays
Enzyme immunoassay (EIA) that involves ELISA has been widely used across clinical laboratories, diagnostic centers, and hospitals for the diagnosis of various diseases. However, with diseases getting more complex, the need to detect smaller bacterial molecules has resulted in the emergence of the rapid automated analyzer, chemiluminescence immunoassay (CLIA). Chemiluminescence is proven to be a highly advantageous and cost-saving method for hospitals. Some of the advantages of CLIA over ELISA include increased sensitivity, reduced reagent consumption, improved precision, applicability to low abundance targets, reduced assay times, and increased throughput. Hence, the use of CLIA is rising, which is expected to positively impact the global bacterial disease diagnostics market growth during the forecast period.
Global bacterial disease diagnostics market: Segmentation analysis
This market research report segments the global bacterial disease diagnostics market by product (instruments, and consumables), and geographic regions (North America, Europe, Asia, and ROW).
Global bacterial disease diagnostics market: High sensitivity and accuracy of chemiluminescence immunoassays
Enzyme immunoassay (EIA) that involves ELISA has been widely used across clinical laboratories, diagnostic centers, and hospitals for the diagnosis of various diseases. However, with diseases getting more complex, the need to detect smaller bacterial molecules has resulted in the emergence of the rapid automated analyzer, chemiluminescence immunoassay (CLIA). Chemiluminescence is proven to be a highly advantageous and cost-saving method for hospitals. Some of the advantages of CLIA over ELISA include increased sensitivity, reduced reagent consumption, improved precision, applicability to low abundance targets, reduced assay times, and increased throughput. Hence, the use of CLIA is rising, which is expected to positively impact the global bacterial disease diagnostics market growth during the forecast period.
Global bacterial disease diagnostics market: Segmentation analysis
This market research report segments the global bacterial disease diagnostics market by product (instruments, and consumables), and geographic regions (North America, Europe, Asia, and ROW).
Comments
Post a Comment